Zhitong Finance App News, ST Renfu (600079.SH) issued an announcement. Recently, the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) received a marketing license approval letter for midazolam injections approved and issued by the UK Medicines and Health Products Administration (MHRA).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.